The "3hr Virtual Seminar - Validation, Verification and Transfer of Analytical Methods - Implementing Guidelines from FDA/EMA, USP and ICH" training has been added to ResearchAndMarkets.com's offering ...
2d
GlobalData on MSNGilead’s lenacapavir applications for HIV gain EMA validationThe latest announcement follows the recent US Food and Drug Administration (FDA) acceptance of the company’s new drug ...
The EUR/JPYtrades flat after a minor sell-off. It hit a low of 155.95 and is currently trading around 156.57.The intraday ...
A coherent strategic framework could be set by 2030, with strong political support, patient advocates underlined.
Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC ...
The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV ...
Foster City, California Tuesday, February 25, 2025, 16:00 Hrs [IST] ...
13d
GlobalData on MSNEU reshapes HTAs: is the industry ready for it?New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.
| Avoid common pitfalls in EU orphan drug market access—learn how local expertise can help navigate pricing, reimbursement, ...
With the European Medicines Agency identifying shortages in more than 30 critical medicines, the single market presents an ...
The Pound Sterling declines to near 1.2630 against the US Dollar as US President Trump threatens to impose reciprocal tariffs ...
Mitsubishi Tanabe Pharma (MTPC) today announced that the European Medicines Agency (EMA) has accepted for review the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results